Correlation Between AstraZeneca PLC and Organogenesis Holdings
Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and Organogenesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and Organogenesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AstraZeneca PLC ADR and Organogenesis Holdings, you can compare the effects of market volatilities on AstraZeneca PLC and Organogenesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of Organogenesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and Organogenesis Holdings.
Diversification Opportunities for AstraZeneca PLC and Organogenesis Holdings
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between AstraZeneca and Organogenesis is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC ADR and Organogenesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organogenesis Holdings and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC ADR are associated (or correlated) with Organogenesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organogenesis Holdings has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and Organogenesis Holdings go up and down completely randomly.
Pair Corralation between AstraZeneca PLC and Organogenesis Holdings
Considering the 90-day investment horizon AstraZeneca PLC is expected to generate 479.14 times less return on investment than Organogenesis Holdings. But when comparing it to its historical volatility, AstraZeneca PLC ADR is 4.51 times less risky than Organogenesis Holdings. It trades about 0.0 of its potential returns per unit of risk. Organogenesis Holdings is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 318.00 in Organogenesis Holdings on October 23, 2024 and sell it today you would earn a total of 16.00 from holding Organogenesis Holdings or generate 5.03% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
AstraZeneca PLC ADR vs. Organogenesis Holdings
Performance |
Timeline |
AstraZeneca PLC ADR |
Organogenesis Holdings |
AstraZeneca PLC and Organogenesis Holdings Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AstraZeneca PLC and Organogenesis Holdings
The main advantage of trading using opposite AstraZeneca PLC and Organogenesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, Organogenesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will offset losses from the drop in Organogenesis Holdings' long position.AstraZeneca PLC vs. DiaMedica Therapeutics | AstraZeneca PLC vs. Seres Therapeutics | AstraZeneca PLC vs. Inhibikase Therapeutics | AstraZeneca PLC vs. Oncolytics Biotech |
Organogenesis Holdings vs. Shuttle Pharmaceuticals | Organogenesis Holdings vs. Lifecore Biomedical | Organogenesis Holdings vs. Redhill Biopharma | Organogenesis Holdings vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |